1. Bloom, P. M. and Nelp, W. B. (1966) Relationship of the excretion of tritiated digoxin to renal function. Amer. J. med. Sci. 251, 133–144.
2. Haustein, K.-O. (1978) Measurement of plasma glycoside level following pengitoxin administration. Europ. J. clin. Pharmacol. 13, 389–391.
3. Haustein, K.-O., Alken, R. G., Lach, H.-J., Becker, U., Rietbrock, N. (im Druck) On the pharmacokinetics of pengitoxin and its cardioactive derivative (16acetyl-gitoxin). Eur. J. Clin. Pharmacol.
4. Haustein, K.-O., Pachaly, Ch., Megges, R. and Franke, P. (1978b) Investigations into the species-specific deacylation of penta-acetyl-gitoxin. Europ. J. clin. Pharmacol. 14, 425–430.
5. Haustein, K.-O., Pachaly, Ch. and Murawski, D. (1978a) Pharmacokinetic investigations with 3H-pentaacetyl-gitoxin in volunteers and in patients with respect to the occurrence of drug latentiation. Int. J. clin. Pharmacol. 16, 285–289.